Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paraneoplastic Syndromes | 1 | 2021 | 8 | 0.740 |
Why?
|
| Hypercalcemia | 1 | 2021 | 12 | 0.740 |
Why?
|
| Carcinoma, Small Cell | 1 | 2021 | 14 | 0.740 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2019 | 4 | 0.650 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2019 | 10 | 0.640 |
Why?
|
| Sarcoma | 1 | 2019 | 28 | 0.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 446 | 0.560 |
Why?
|
| Neuroblastoma | 4 | 2022 | 56 | 0.530 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 567 | 0.480 |
Why?
|
| Ring Chromosomes | 1 | 2011 | 1 | 0.380 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2011 | 1 | 0.380 |
Why?
|
| Polyps | 1 | 2011 | 2 | 0.380 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 20 | 0.380 |
Why?
|
| Esophageal Diseases | 1 | 2011 | 13 | 0.370 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 31 | 0.370 |
Why?
|
| Genetic Testing | 1 | 2011 | 64 | 0.360 |
Why?
|
| Esophagus | 1 | 2011 | 69 | 0.360 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 11 | 0.350 |
Why?
|
| Transcription Factors | 3 | 2021 | 512 | 0.340 |
Why?
|
| Biomarkers, Tumor | 3 | 2021 | 377 | 0.310 |
Why?
|
| Hyaluronic Acid | 2 | 2020 | 95 | 0.310 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2020 | 89 | 0.290 |
Why?
|
| Eye Proteins | 2 | 2019 | 197 | 0.270 |
Why?
|
| Humans | 17 | 2022 | 27160 | 0.230 |
Why?
|
| Capillaries | 2 | 2021 | 32 | 0.220 |
Why?
|
| Infant | 4 | 2021 | 965 | 0.210 |
Why?
|
| Child | 6 | 2021 | 2158 | 0.210 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 186 | 0.190 |
Why?
|
| Aldo-Keto Reductase Family 1 Member C3 | 3 | 2017 | 21 | 0.190 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 8 | 0.190 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2021 | 9 | 0.190 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 11 | 0.190 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 20 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 36 | 0.180 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 89 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 64 | 0.180 |
Why?
|
| Testis | 1 | 2021 | 39 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 111 | 0.180 |
Why?
|
| DNA Helicases | 1 | 2021 | 51 | 0.180 |
Why?
|
| Laparoscopy | 1 | 2022 | 143 | 0.170 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2009 | 16 | 0.170 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 2 | 2009 | 17 | 0.170 |
Why?
|
| SMARCB1 Protein | 1 | 2019 | 5 | 0.160 |
Why?
|
| Trisomy | 1 | 2019 | 18 | 0.160 |
Why?
|
| Tight Junctions | 1 | 2019 | 29 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 245 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2019 | 76 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2021 | 331 | 0.150 |
Why?
|
| Liver | 1 | 2021 | 424 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 262 | 0.150 |
Why?
|
| Placenta | 1 | 2018 | 74 | 0.150 |
Why?
|
| Platelet Count | 1 | 2018 | 111 | 0.150 |
Why?
|
| Androstane-3,17-diol | 1 | 2017 | 9 | 0.150 |
Why?
|
| Anabolic Agents | 1 | 2017 | 12 | 0.150 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 18 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2017 | 31 | 0.150 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 37 | 0.140 |
Why?
|
| Lymph Nodes | 1 | 2017 | 98 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2017 | 67 | 0.140 |
Why?
|
| Asparaginase | 1 | 2016 | 2 | 0.140 |
Why?
|
| Voriconazole | 1 | 2016 | 4 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2016 | 11 | 0.140 |
Why?
|
| Gene Amplification | 2 | 2019 | 22 | 0.130 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 23 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 38 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2016 | 59 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 93 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 481 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 510 | 0.120 |
Why?
|
| Female | 5 | 2021 | 14661 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 367 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 271 | 0.120 |
Why?
|
| Pregnancy | 1 | 2018 | 1154 | 0.120 |
Why?
|
| Male | 6 | 2021 | 13040 | 0.110 |
Why?
|
| Young Adult | 1 | 2019 | 2633 | 0.100 |
Why?
|
| PAX3 Transcription Factor | 1 | 2011 | 1 | 0.100 |
Why?
|
| Abnormal Karyotype | 1 | 2011 | 1 | 0.100 |
Why?
|
| PAX7 Transcription Factor | 1 | 2011 | 2 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 3 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2011 | 17 | 0.090 |
Why?
|
| Esophagectomy | 1 | 2011 | 8 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 12 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 17 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 22 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 37 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 34 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2011 | 23 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 660 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2009 | 7 | 0.080 |
Why?
|
| Animals | 5 | 2022 | 10093 | 0.080 |
Why?
|
| Cryptorchidism | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 185 | 0.080 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 54 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 75 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 98 | 0.080 |
Why?
|
| Disease Progression | 2 | 2019 | 458 | 0.070 |
Why?
|
| Mice | 3 | 2020 | 4478 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2286 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1406 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 455 | 0.060 |
Why?
|
| Middle Aged | 2 | 2011 | 6913 | 0.050 |
Why?
|
| Computers | 1 | 2022 | 29 | 0.050 |
Why?
|
| Needles | 1 | 2022 | 26 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 50 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 20 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2017 | 1379 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 16 | 0.050 |
Why?
|
| Swine | 1 | 2022 | 221 | 0.050 |
Why?
|
| Virus Replication | 1 | 2021 | 63 | 0.050 |
Why?
|
| Papio | 1 | 2021 | 78 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 69 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 74 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 177 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 763 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2019 | 28 | 0.040 |
Why?
|
| Formaldehyde | 1 | 2019 | 10 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 12 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 440 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 72 | 0.040 |
Why?
|
| Chorionic Villi | 1 | 2018 | 7 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2018 | 15 | 0.040 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 14 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2018 | 38 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 291 | 0.040 |
Why?
|
| Thymus Neoplasms | 1 | 2017 | 8 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2018 | 116 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 47 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2017 | 21 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2017 | 36 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2018 | 116 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 119 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2017 | 95 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 240 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 310 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 862 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 2993 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 229 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2009 | 1102 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 241 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 775 | 0.030 |
Why?
|
| Retina | 1 | 2017 | 422 | 0.030 |
Why?
|
| Puberty | 1 | 2009 | 13 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 1944 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 5231 | 0.010 |
Why?
|
| Adult | 1 | 2009 | 7506 | 0.010 |
Why?
|